Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complication in Systemic Lupus Erythematosus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00876616
What this trial is testing

Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Zhi-Hong Liu, M.D. 362
Testing effectiveness (Phase 2)Looking for participantsNCT06434363
What this trial is testing

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Who this might be right for
Autoimmune DisordersSystemic SclerosisSystemic Lupus Erythematosus+2 more
M.D. Anderson Cancer Center 47
Testing effectiveness (Phase 2)Study completedNCT03610516
What this trial is testing

Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis.

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 57
Early research (Phase 1)Looking for participantsNCT06308978
What this trial is testing

FT819 in B-cell Mediated Autoimmune Disease

Who this might be right for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Systemic Sclerosis (SSc)+2 more
Fate Therapeutics 244
Post-approval studies (Phase 4)Looking for participantsNCT07225387
What this trial is testing

Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

Who this might be right for
Lupus Nephritis
NephroNet, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00050713
What this trial is testing

Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy

Who this might be right for
Membranous GlomerulonephritisLupus Membranous Nepropathy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 12
Not applicableStudy completedNCT05260255
What this trial is testing

Effect of Vitamin D Supplement on Disease Activity in SLE

Who this might be right for
Vitamin D DeficiencyHypocalcemiaHyperparathyroidism+1 more
Department of Medical Services Ministry of Public Health of Thailand 100
Post-approval studies (Phase 4)Looking for participantsNCT07760480
What this trial is testing

Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone, Mycofenolate Mofetil and Voclosporin as Compared to Mycofenolate Mofetil and Prednisolone

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus (SLE)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 55
Not applicableLooking for participantsNCT02954939
What this trial is testing

The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
The University of Hong Kong 50
Testing effectiveness (Phase 2)Ended earlyNCT05938725
What this trial is testing

KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

Who this might be right for
Lupus NephritisLupus Nephritis - World Health Organization (WHO) Class IIILupus Nephritis - WHO Class IV
Kyverna Therapeutics 6
Very early researchLooking for participantsNCT07107659
What this trial is testing

Safety and Efficacy of ONT01 in Lupus

Who this might be right for
Lupus Nephritis (LN)Lupus Nephritis - WHO Class IIILupus Nephritis - WHO Class IV+5 more
Hospital for Special Surgery, New York 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT05732402
What this trial is testing

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyMembranous Nephropathy+1 more
Alpine Immune Sciences, Inc. 72
Large-scale testing (Phase 3)WithdrawnNCT05609812
What this trial is testing

Atacicept in Subjects With Active Lupus Nephritis (COMPASS)

Who this might be right for
Lupus Nephritis (LN)
Vera Therapeutics, Inc.
Early research (Phase 1)Ended earlyNCT00479622
What this trial is testing

Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Wyeth is now a wholly owned subsidiary of Pfizer 20
Early research (Phase 1)Study completedNCT05780515
What this trial is testing

ANX009 in Adult Participants With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Annexon, Inc. 7
Large-scale testing (Phase 3)Looking for participantsNCT07201129
What this trial is testing

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

Who this might be right for
Nephritis, LupusLupus Erythematosus, Systemic
Viatris Innovation GmbH 300
Large-scale testing (Phase 3)Ended earlyNCT00573157
What this trial is testing

The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis

Who this might be right for
Lupus Nephritis
EMD Serono 6
Not applicableLooking for participantsNCT06902844
What this trial is testing

Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
Tongji Hospital 6
Testing effectiveness (Phase 2)Study completedNCT02770170
What this trial is testing

Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Boehringer Ingelheim 121
Testing effectiveness (Phase 2)Looking for participantsNCT06897930
What this trial is testing

Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Who this might be right for
Lupus Erythematosus, Systemic
AstraZeneca 150
Next Page